These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29281822)

  • 21. How type II CRISPR-Cas establish immunity through Cas1-Cas2-mediated spacer integration.
    Xiao Y; Ng S; Nam KH; Ke A
    Nature; 2017 Oct; 550(7674):137-141. PubMed ID: 28869593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems.
    Burmistrz M; Dudek B; Staniec D; Rodriguez Martinez JI; Bochtler M; Potempa J; Pyrc K
    J Bacteriol; 2015 Aug; 197(16):2631-41. PubMed ID: 26013482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Directional R-Loop Formation by the CRISPR-Cas Surveillance Complex Cascade Provides Efficient Off-Target Site Rejection.
    Rutkauskas M; Sinkunas T; Songailiene I; Tikhomirova MS; Siksnys V; Seidel R
    Cell Rep; 2015 Mar; 10(9):1534-1543. PubMed ID: 25753419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR adaptation in Escherichia coli subtypeI-E system.
    Kiro R; Goren MG; Yosef I; Qimron U
    Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragmentation of the CRISPR-Cas Type I-B signature protein Cas8b.
    Richter H; Rompf J; Wiegel J; Rau K; Randau L
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2993-3000. PubMed ID: 28238733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
    Numata T; Inanaga H; Sato C; Osawa T
    J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cas Systems in Prokaryotes.
    Burmistrz M; Pyrć K
    Pol J Microbiol; 2015; 64(3):193-202. PubMed ID: 26638527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses.
    Jackson RN; Wiedenheft B
    Mol Cell; 2015 Jun; 58(5):722-8. PubMed ID: 26028539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptation in CRISPR-Cas Systems.
    Sternberg SH; Richter H; Charpentier E; Qimron U
    Mol Cell; 2016 Mar; 61(6):797-808. PubMed ID: 26949040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered stoichiometry Escherichia coli Cascade complexes with shortened CRISPR RNA spacers are capable of interference and primed adaptation.
    Kuznedelov K; Mekler V; Lemak S; Tokmina-Lukaszewska M; Datsenko KA; Jain I; Savitskaya E; Mallon J; Shmakov S; Bothner B; Bailey S; Yakunin AF; Severinov K; Semenova E
    Nucleic Acids Res; 2016 Dec; 44(22):10849-10861. PubMed ID: 27738137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type III CRISPR-Cas Immunity: Major Differences Brushed Aside.
    Tamulaitis G; Venclovas Č; Siksnys V
    Trends Microbiol; 2017 Jan; 25(1):49-61. PubMed ID: 27773522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction.
    Han W; Li Y; Deng L; Feng M; Peng W; Hallstrøm S; Zhang J; Peng N; Liang YX; White MF; She Q
    Nucleic Acids Res; 2017 Feb; 45(4):1983-1993. PubMed ID: 27986854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9 for genome editing: progress, implications and challenges.
    Zhang F; Wen Y; Guo X
    Hum Mol Genet; 2014 Sep; 23(R1):R40-6. PubMed ID: 24651067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foreign DNA capture during CRISPR-Cas adaptive immunity.
    Nuñez JK; Harrington LB; Kranzusch PJ; Engelman AN; Doudna JA
    Nature; 2015 Nov; 527(7579):535-8. PubMed ID: 26503043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
    Majsec K; Bolt EL; Ivančić-Baće I
    BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-time observation of CRISPR spacer acquisition by Cas1-Cas2 integrase.
    Budhathoki JB; Xiao Y; Schuler G; Hu C; Cheng A; Ding F; Ke A
    Nat Struct Mol Biol; 2020 May; 27(5):489-499. PubMed ID: 32367067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-time observation of multiple-protein complex formation with single-molecule FRET.
    Bae W; Bae W; Choi MG; Hyeon C; Shin YK; Yoon TY
    J Am Chem Soc; 2013 Jul; 135(28):10254-7. PubMed ID: 23808880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a Three-Color Prism-Based TIRF Microscope to Study the Interactions and Dynamics of Macromolecules.
    Fairlamb MS; Whitaker AM; Bain FE; Spies M; Freudenthal BD
    Biology (Basel); 2021 Jun; 10(7):. PubMed ID: 34201434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a.
    Sundaresan R; Parameshwaran HP; Yogesha SD; Keilbarth MW; Rajan R
    Cell Rep; 2017 Dec; 21(13):3728-3739. PubMed ID: 29281823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.